Abstract
Technetium-99m methoxyisobutylisonitrile (99mTc-MIBI) uptake is known to be
increased in breast cancer because of increased blood flow from angiogenesis and
heightened metabolism. We performed a 99mTc-MIBI scan in a patient with mammary
Paget's disease. The patient had underlying invasive cancer in the same side of
the breast. 99mTc-MIBI scan exhibited a scintigraphic image of the uptake from
the invasive cancer lesion located deeply in the breast toward the epidermis.
99mTc-MIBI showed an uptake in the deeply located invasive cancer lesion as well
as nipple lesion. Especially, the delayed phase of Tc-MIBI scan demonstrated the
tumor site more accurately. In conclusion, 99mTc-MIBI scan could be a useful
adjunct to clinical decision making in the management of Paget's disease of the
breast.